Sontag Advisory »

Gain Therapeutics shares owned by Sontag Advisory

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $54k 17k 3.22

More positions owned by Sontag Advisory

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Growth Etf (VUG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core Univrsl Usd (IUSB)
Vanguard Malvern Fds Strm Infproidx (VTIP)

View all positions for Sontag Advisory

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
Susquehanna International
Jones Financial Companies, L.L
Vanguard Group
Cambridge Investment Research Advisors
DME Capital Management
Geode Capital Management
Citadel Advisors
Jane Street
BlackRock
Cresset Asset Management
State Street Corporation
LPL Financial
Northern Trust

View all funds holding Gain Therapeutics